Enwei Pharmaceutical Revenue

Enwei Pharmaceutical had revenue of 252.72M CNY in the quarter ending June 30, 2025, with 23.48% growth. This brings the company's revenue in the last twelve months to 873.20M, up 12.22% year-over-year. In the year 2024, Enwei Pharmaceutical had annual revenue of 812.13M with 3.43% growth.

Revenue (ttm)

873.20M

Revenue Growth

+12.22%

P/S Ratio

3.66

Revenue / Employee

564.08K

Employees

1,548

Market Cap

3.19B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	812.13M	26.94M	3.43%
Dec 31, 2023	785.19M	93.62M	13.54%
Jan 1, 2023	691.57M	11.88M	1.75%
Jan 1, 2022	679.70M	45.54M	7.18%
Dec 31, 2020	634.16M	13.49M	2.17%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	30.15B
WuXi AppTec	41.90B
Shenzhen Mindray Bio-Medical Electronics	32.94B
Sichuan Biokin Pharmaceutical	441.19M
Zhangzhou Pientzehuang Pharmaceutical.,	10.52B
Shanghai United Imaging Healthcare	10.98B
Aier Eye Hospital Group	21.94B
Yunnan Baiyao Group Co.,Ltd	40.84B

Revenue Rankings